Soins Gerontol. 2013 Jan-Feb;(99):35-9. French
Similar survival rates with first-line gefitinib, gemcitabine, or docetaxel in a randomized phase II trial in elderly patients with advanced non-small cell lung cancer and a poor performance status (IFCT-0301)
J Geriatr Oncol. 2015 May;6(3):233-40. doi: 10.1016/j.jgo.2015.02.002. Epub 2015 Feb 16
Is There a Survival Benefit of First-Line Epidermal Growth Factor Receptor Tyrosine-Kinase Inhibitor Monotherapy Versus Chemotherapy in Patients with Advanced Non-Small-Cell Lung Cancer?: A Meta-Analysis
Target Oncol. 2016 Feb;11(1):41-7. doi: 10.1007/s11523-015-0373-x
Doublet chemotherapy vs. single-agent therapy with 5FU in elderly patients with metastatic colorectal cancer. a meta-analysis.
Int J Colorectal Dis. 2015 Oct;30(10):1305-10. doi: 10.1007/s00384-015-2296-5. Epub 2015 Jun 23. Review.
Chronological Age and Risk of Chemotherapy Nonfeasibility: A Real-Life Cohort Study of 153 Stage II or III Colorectal Cancer Patients Given Adjuvant-modified FOLFOX6
Am J Clin Oncol. 2018 Jan;41(1):73-80. doi: 10.1097/COC.0000000000000233.
Soins Gerontol. 2017 Sep – Oct;22(127):30-33. doi: 10.1016/j.sger.2017.06.010. Review. French
Impact of the addition of bevacizumab, oxaliplatin or irinotecan to fluoropyrimidin in the first-line treatment of metastatic colorectal cancer in elderly patients.
J Clin Oncol, 2017. 35.15_suppl.e15034 Journal of Clinical Oncology 35, no. 15_supp
Is there a clinical benefit of anti-PD-1 in patients older than 75 years with previously treated solid tumour?
J Clin Oncol 34, 2016 (suppl; abstr 3070)
Anti PD-1 (nivolumab, pembrolizumab) or anti PD-L1 (atezolizumab) versus docetaxel for previously treated patients with advanced NSCLC: A meta-analysis.
Bichemotherapy versus single-agent therapy with 5FU in elderly patients with metastatic colorectal cancer: A meta-analysis.
J Clin Oncol 32:5s, 2014 (suppl; abstr 3570)
Darbepoetin Alfa in older patients with chemotherapy induced anaemia: Is the recommended initial dose optimal for elderly?
SIOG 2012 Volume 3, Supplement 1, Page S97
Pain reports and pain medication treatment in elderly patients with cancer: A retrospective cohort study of 311 patients
SIOG 2014 Volume 5, Supplement 2, Page S75
Impact of co-morbidities on gemcitabine as single agent chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC)
SIOG 2013 Volume 4, Supplement 1, Pages S38–S39
SIOG 2013 Volume 4, Supplement 1, Pages S48–S49
Benefit of tyrosine kinase inhibitors among the older compared with younger patients in non-small cell lung cancer
The European Cancer Congress 2015
Comparison of efficacy of new therapies between younger and older patients with relapsed and refractory multiple myeloma: a meta-analysis
Annals of Oncology, Volume 28, Issue suppl_5, 1 September 2017, mdx373.005